Drugs / MCS
last change Oct 2009 re-read 3 minutes ago

MCS

Developed for
benign prostatic hyperplasia

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 3 NCT00501371 Comparator Jul 2007 → Oct 2009 benign prostatic hyperplasia Health Ever Bio-Tech Co., Ltd. Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MCS ClinicalTrials.gov intervention name — accepted as the source's own label NCT00501371 ↗